0001596783-19-000025.txt : 20190325
0001596783-19-000025.hdr.sgml : 20190325
20190325175001
ACCESSION NUMBER: 0001596783-19-000025
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190321
FILED AS OF DATE: 20190325
DATE AS OF CHANGE: 20190325
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gennadios Aristippos
CENTRAL INDEX KEY: 0001612357
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36587
FILM NUMBER: 19703612
MAIL ADDRESS:
STREET 1: C/O CATALENT, INC.
STREET 2: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Catalent, Inc.
CENTRAL INDEX KEY: 0001596783
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208737688
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
BUSINESS PHONE: (732) 537-6200
MAIL ADDRESS:
STREET 1: 14 SCHOOLHOUSE ROAD
CITY: SOMERSET
STATE: NJ
ZIP: 08873
FORMER COMPANY:
FORMER CONFORMED NAME: PTS Holdings Corp.
DATE OF NAME CHANGE: 20140113
4
1
wf-form4_155355058624331.xml
FORM 4
X0306
4
2019-03-21
0
0001596783
Catalent, Inc.
CTLT
0001612357
Gennadios Aristippos
C/O CATALENT, INC.
14 SCHOOLHOUSE ROAD
SOMERSET
NJ
08873
0
1
0
0
President, Softgel Tech.
Common Stock
2019-03-21
4
M
0
13528
10.71
A
44862
D
Common Stock
2019-03-21
4
F
0
5794
42.17
D
39068
D
Common Stock
2019-03-21
4
F
0
950
42.16
D
38118
D
Common Stock
2019-03-21
4
S
0
3326
42.17
D
34792
D
Common Stock
2019-03-21
4
S
0
66
42.91
D
34726
D
Options to purchase Common Stock
10.71
2019-03-21
4
M
0
13528
0
D
2016-09-09
2019-10-23
Common Stock
13528.0
0
D
This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person in order to implement a plan of financial diversification.
Includes restricted stock units.
Volume-weighted average price. These shares were sold in multiple transactions at prices ranging from $41.84 to $42.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
On October 23, 2009, the reporting person was granted options to purchase 23,240 shares of common stock of the Issuer, which partially vested and became exercisable based on satisfaction of certain performance-based vesting criteria on September 9, 2016. (S1116, S1159)
/s/ Stephanie L. Mariconda, attorney-in-fact
2019-03-25